Skip to main content
Clinical Trials/NCT00562393
NCT00562393
Completed
Not Applicable

Effects of Excess Energy Intake on Metabolic Risk

Garvan Institute of Medical Research1 site in 1 country41 target enrollmentApril 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insulin Resistance
Sponsor
Garvan Institute of Medical Research
Enrollment
41
Locations
1
Primary Endpoint
Insulin sensitiviy by hyperinsulinemic clamp
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The prevalence of obesity has reached epidemic proportions and is associated with the development of insulin resistance and type 2 diabetes (T2DM). A unifying theme has emerged over the past few years suggesting that lipid oversupply to metabolic organs responsible for glucose regulation leads to insulin resistance. Fitting with this, we and others have shown that increased lipid accumulation within skeletal muscle and/or liver is associated with impaired glucose uptake. However, the underlying mechanisms that mediate changes in muscle lipid metabolism are not yet known. The overall aim of this project is to examine metabolic effects of experimental weight gain in lean and overweight individuals with and without a genetic predisposition to type 2 diabetes. We hypothesise that lean subjects will increase fatty acid oxidation and upregulate mitochondrial oxidative capacity in muscle following overfeeding to protect against body weight gain and insulin resistance, but overweight subjects with a genetic predisposition to T2DM will have a defect in this ability.

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
December 2009
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Jerry Greenfield

Head of Endocrinology Department St Vincent's Hospital Sydney

Garvan Institute of Medical Research

Eligibility Criteria

Inclusion Criteria

  • Sedentary (\<60 min formal exercise per week)
  • Aged 20-65 years

Exclusion Criteria

  • Personal history of diabetes, cardiovascular disease or hypertension
  • Recent weight change (larger than 4kg in the past 3 months)
  • Regular use of medications, except oral contraceptives
  • Individuals with alcoholism or other substance abuse
  • Pregnancy or lactation, women who are planning to become pregnant or who are not using adequate measures of birth control.

Outcomes

Primary Outcomes

Insulin sensitiviy by hyperinsulinemic clamp

Time Frame: 28-days

Secondary Outcomes

  • Fat oxidation (whole body RQ and C-14 palmitate), mitochondrial function(28-days)

Study Sites (1)

Loading locations...

Similar Trials